Marsha Linehan makes it out of a long-term psychiatric hospital and vows to develop a better approach to suicidality, reinventing therapy for borderline personality disorder. 

CME: Take the CME Post-Test for this Episode

Published On: 01/05/2026

Duration: 16 minutes, 50 seconds

Chris Aiken, MD and Kellie Newsome, PMHNP have disclosed no relevant financial or other interests in any commercial companies pertaining to this educational activity.

How a tip from Carl Jung inspired Alcoholics Anonymous and the 12-step recovery movement. 

CME: Take the CME Post-Test for this Episode

Published On: 12/29/2025

Duration: 08 minutes, 55 seconds

Chris Aiken, MD and Kellie Newsome, PMHNP have disclosed no relevant financial or other interests in any commercial companies pertaining to this educational activity.

Are psychosis and OCD ever normal? We explore this question from Carl Jung’s breakdown to a new neurologic condition, hyperphantasia.

CME: Take the CME Post-Test for this Episode

Published On: 12/22/2025

Duration: 15 minutes, 41 seconds

Chris Aiken, MD and Kellie Newsome, PMHNP have disclosed no relevant financial or other interests in any commercial companies pertaining to this educational activity.

Today’s episode is one we’ve been sitting with for a long time. We’re talking about how to survive psychologically in a world where hatred is persistent, not abstract, not metaphorical but recurring, and sometimes lethal.

CME: Take the CME Post-Test for this Episode

Published On: 12/19/2025

Duration: 19 minutes, 01 seconds

Joshua Feder, MD, and Mara Goverman, LCSW, have disclosed no relevant financial or other interests in any commercial companies pertaining to this educational activity.

Some of the people who revolutionized psychiatry lived with mental illness themselves. 

CME: Take the CME Post-Test for this Episode

Published On: 12/15/2025

Duration: 15 minutes, 15 seconds

Chris Aiken, MD and Kellie Newsome, PMHNP have disclosed no relevant financial or other interests in any commercial companies pertaining to this educational activity.

How to help bipolar patients manage holiday stress, and a new drug interaction with lithium and GLP1 agonists like semaglutide (Ozempic).

CME: Take the CME Post-Test for this Episode

Published On: 12/08/2025

Duration: 18 minutes, 33 seconds

Chris Aiken, MD has disclosed no relevant financial or other interests in any commercial companies pertaining to this educational activity.

SAINT TMS is now available. We take a closer look at its record-breaking effect size.

CME: Take the CME Post-Test for this Episode

Published On: 12/01/2025

Duration: 16 minutes, 04 seconds

Chris Aiken, MD and Kellie Newsome, PMHNP have disclosed no relevant financial or other interests in any commercial companies pertaining to this educational activity.

SAINT TMS is now available. We take a closer look at its record-breaking effect size.

CME: Take the CME Post-Test for this Episode

Published On: 11/24/2025

Duration: 09 minutes, 53 seconds

Chris Aiken, MD and Kellie Newsome, PMHNP have disclosed no relevant financial or other interests in any commercial companies pertaining to this educational activity.

Dr. Kenneth Levy provides an overview of the major evidence-based treatments for Borderline Personality Disorder and explains why clinicians shouldn’t limit themselves to just one model. Despite their different styles, these treatments share core elements and similar effectiveness, and Dr. Levy makes the case that therapists best serve patients when they understand multiple approaches and remain flexible in how they use them.

Published On: 11/20/2025

Duration: 48 minutes, 12 seconds

For years, autism care has centered on one model, but that’s changing. The American Academy of Child and Adolescent Psychiatry just redefined what evidence-based care really means. This shift could transform how we support children and families.

CME: Take the CME Post-Test for this Episode

Published On: 11/17/2025

Duration: 24 minutes, 07 seconds

Joshua Feder, MD, and Mara Goverman, LCSW, have disclosed no relevant financial or other interests in any commercial companies pertaining to this educational activity.